(r)​linezolid

(R)-Linezolid, an impurity of Linezolid, inhibits the initiation of bacterial protein synthesis.

Linezolid (Standard) is a reference standard for research and analysis in studies involving Linezolid. Linezolid (PNU-100766), the first of the oxazolidinone class, is a synthetic antibiotic used for the therapy of infections resulted from multi-resistant bacteria including methicillin-resistant Staphylococcus aureus (MRSA) and streptococcus. The drug takes effect as the inhibitor of the initiation of bacterial protein synthesis.

PNU-100766-D8 is a deuterium-labeled form of PNU-100766 (TMSM-3494). Linezolid (PNU-100766) is the first member of the oxazolidinone class of synthetic antibiotics, functioning by inhibiting the initiation of bacterial protein synthesis, thereby exhibiting anti-infective properties.

Linezolid-D3 (Standard) is a reference standard of Linezolid-D3 intended for quantitative analysis, quality control, and related biochemical research applications. Linezolid D3 is the deuterium-labeled isotope of Linezolid. It is an artificially synthesized antibiotic designed to inhibit the initiation process of bacterial protein synthesis.

Linezolid (PNU-100766), the first of the oxazolidinone class, is a synthetic antibiotic used for the therapy of infections resulted from multi-resistant bacteria including methicillin-resistant Staphylococcus aureus (MRSA) and streptococcus. The drug takes effect as the inhibitor of the initiation of bacterial protein synthesis.

Linezolid-D3 is a synthetic antibiotic designed to halt the initiation of bacterial protein synthesis.